ABCL icon

AbCellera Biologics
ABCL

Overview Fund Trends Analyst Outlook Journalist POV
Buy
Hold
Sell

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
Avg. target
$7
20% upside
High target

1 analyst rating

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Stifel
Stifel
Stephen Willey
75% 1-yr ABCL win rate
8 Aug ‘25 2 months ago